Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONVO

Organovo (ONVO) Stock Price, News & Analysis

Organovo logo

About Organovo Stock (NASDAQ:ONVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.66
$15.24
52-Week Range
N/A
Volume
243,634 shs
Average Volume
617,505 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organovo and its competitors with MarketBeat's FREE daily newsletter.

ONVO Stock News Headlines

Two new option listings and one option delisting on April 24th
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech
VivoSim to Carry Forward Organovo 3D Bioprinting
Organovo expects to meet requirements for continued listing on Nasdaq
See More Headlines

ONVO Stock Analysis - Frequently Asked Questions

Organovo Holdings, Inc. (NASDAQ:ONVO) announced its quarterly earnings data on Wednesday, February, 19th. The medical research company reported ($2.28) EPS for the quarter, beating analysts' consensus estimates of ($2.52) by $0.24. The medical research company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.05 million. Organovo had a negative net margin of 10,151.64% and a negative trailing twelve-month return on equity of 346.26%.

Organovo shares reverse split before market open on Friday, March 21st 2025.The 1-12 reverse split was announced on Wednesday, March 19th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 20th 2025. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organovo investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Brainstorm Cell Therapeutics (BCLI), AST SpaceMobile (ASTS) and Virgin Galactic (SPCE).

Company Calendar

Last Earnings
2/19/2025
Today
8/08/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONVO
CIK
1497253
Fax
N/A
Employees
20
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($10.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.67 million
Net Margins
-10,151.64%
Pretax Margin
-10,150.00%
Return on Equity
-346.26%
Return on Assets
-187.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.72
Quick Ratio
1.72

Sales & Book Value

Annual Sales
$122 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,701,000
Free Float
14,794,000
Market Cap
$3.47 million
Optionable
Optionable
Beta
1.13

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ONVO) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners